Pathogen manipulation of cIL-10 signaling pathways

Opportunities for vaccine development?

Meghan K. Eberhardt, Peter A. Barry

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Interleukin-10 (IL-10) is a tightly regulated, pleiotropic cytokine that has profound effects on all facets of the immune system, eliciting cell-type-specific responses within cells expressing the IL-10 receptor (IL-10R). It is considered a master immune regulator, and imbalances in IL-10 expression, resulting from either inherent or infectious etiologies, have far reaching clinical ramifications. Regarding infectious diseases, there has been accumulating recognition that many pathogens, particularly those that establish lifelong persistence, share a commonality of their natural histories: manipulation of IL-10-mediated signaling pathways. Multiple viral, bacterial, protozoal, and fungal pathogens appear to have evolved mechanisms to co-opt normal immune functions, including those involving IL-10R-mediated signaling, and immune effector pathways away from immune-mediated protection toward environments of immune evasion, suppression, and tolerance. As a result, pathogens can persist for the life of the infected host, many of whom possess otherwise competent immune systems. Because of pathogenic avoidance of immune clearance, persistent infections can exact incalculable physical and financial costs, and represent some of the most vexing challenges for improvements in human health. Enormous benefits could be gained by the development of efficient prevention and/or therapeutic strategies that block primary infection, or clear the infection. There are now precedents that indicate that modalities focusing on pathogen-mediated manipulation of IL-10 signaling may have clinical benefit.

Original languageEnglish (US)
Title of host publicationCurrent Topics in Microbiology and Immunology
PublisherSpringer Verlag
Pages93-128
Number of pages36
Volume380
ISBN (Print)9783662434918
DOIs
StatePublished - 2014

Publication series

NameCurrent Topics in Microbiology and Immunology
Volume380
ISSN (Print)0070217X
ISSN (Electronic)21969965

Fingerprint

Interleukin-10
Interleukin-10 Receptors
Vaccines
Immune System
Infection
Immune Evasion
Immune Tolerance
Natural History
Communicable Diseases
Cytokines
Costs and Cost Analysis
Health
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Microbiology (medical)
  • Immunology
  • Microbiology

Cite this

Eberhardt, M. K., & Barry, P. A. (2014). Pathogen manipulation of cIL-10 signaling pathways: Opportunities for vaccine development? In Current Topics in Microbiology and Immunology (Vol. 380, pp. 93-128). (Current Topics in Microbiology and Immunology; Vol. 380). Springer Verlag. https://doi.org/10.1007/978-3-662-43492-5-5

Pathogen manipulation of cIL-10 signaling pathways : Opportunities for vaccine development? / Eberhardt, Meghan K.; Barry, Peter A.

Current Topics in Microbiology and Immunology. Vol. 380 Springer Verlag, 2014. p. 93-128 (Current Topics in Microbiology and Immunology; Vol. 380).

Research output: Chapter in Book/Report/Conference proceedingChapter

Eberhardt, MK & Barry, PA 2014, Pathogen manipulation of cIL-10 signaling pathways: Opportunities for vaccine development? in Current Topics in Microbiology and Immunology. vol. 380, Current Topics in Microbiology and Immunology, vol. 380, Springer Verlag, pp. 93-128. https://doi.org/10.1007/978-3-662-43492-5-5
Eberhardt MK, Barry PA. Pathogen manipulation of cIL-10 signaling pathways: Opportunities for vaccine development? In Current Topics in Microbiology and Immunology. Vol. 380. Springer Verlag. 2014. p. 93-128. (Current Topics in Microbiology and Immunology). https://doi.org/10.1007/978-3-662-43492-5-5
Eberhardt, Meghan K. ; Barry, Peter A. / Pathogen manipulation of cIL-10 signaling pathways : Opportunities for vaccine development?. Current Topics in Microbiology and Immunology. Vol. 380 Springer Verlag, 2014. pp. 93-128 (Current Topics in Microbiology and Immunology).
@inbook{0c311cacb8284a66bfff71c6ad8a37d1,
title = "Pathogen manipulation of cIL-10 signaling pathways: Opportunities for vaccine development?",
abstract = "Interleukin-10 (IL-10) is a tightly regulated, pleiotropic cytokine that has profound effects on all facets of the immune system, eliciting cell-type-specific responses within cells expressing the IL-10 receptor (IL-10R). It is considered a master immune regulator, and imbalances in IL-10 expression, resulting from either inherent or infectious etiologies, have far reaching clinical ramifications. Regarding infectious diseases, there has been accumulating recognition that many pathogens, particularly those that establish lifelong persistence, share a commonality of their natural histories: manipulation of IL-10-mediated signaling pathways. Multiple viral, bacterial, protozoal, and fungal pathogens appear to have evolved mechanisms to co-opt normal immune functions, including those involving IL-10R-mediated signaling, and immune effector pathways away from immune-mediated protection toward environments of immune evasion, suppression, and tolerance. As a result, pathogens can persist for the life of the infected host, many of whom possess otherwise competent immune systems. Because of pathogenic avoidance of immune clearance, persistent infections can exact incalculable physical and financial costs, and represent some of the most vexing challenges for improvements in human health. Enormous benefits could be gained by the development of efficient prevention and/or therapeutic strategies that block primary infection, or clear the infection. There are now precedents that indicate that modalities focusing on pathogen-mediated manipulation of IL-10 signaling may have clinical benefit.",
author = "Eberhardt, {Meghan K.} and Barry, {Peter A.}",
year = "2014",
doi = "10.1007/978-3-662-43492-5-5",
language = "English (US)",
isbn = "9783662434918",
volume = "380",
series = "Current Topics in Microbiology and Immunology",
publisher = "Springer Verlag",
pages = "93--128",
booktitle = "Current Topics in Microbiology and Immunology",

}

TY - CHAP

T1 - Pathogen manipulation of cIL-10 signaling pathways

T2 - Opportunities for vaccine development?

AU - Eberhardt, Meghan K.

AU - Barry, Peter A.

PY - 2014

Y1 - 2014

N2 - Interleukin-10 (IL-10) is a tightly regulated, pleiotropic cytokine that has profound effects on all facets of the immune system, eliciting cell-type-specific responses within cells expressing the IL-10 receptor (IL-10R). It is considered a master immune regulator, and imbalances in IL-10 expression, resulting from either inherent or infectious etiologies, have far reaching clinical ramifications. Regarding infectious diseases, there has been accumulating recognition that many pathogens, particularly those that establish lifelong persistence, share a commonality of their natural histories: manipulation of IL-10-mediated signaling pathways. Multiple viral, bacterial, protozoal, and fungal pathogens appear to have evolved mechanisms to co-opt normal immune functions, including those involving IL-10R-mediated signaling, and immune effector pathways away from immune-mediated protection toward environments of immune evasion, suppression, and tolerance. As a result, pathogens can persist for the life of the infected host, many of whom possess otherwise competent immune systems. Because of pathogenic avoidance of immune clearance, persistent infections can exact incalculable physical and financial costs, and represent some of the most vexing challenges for improvements in human health. Enormous benefits could be gained by the development of efficient prevention and/or therapeutic strategies that block primary infection, or clear the infection. There are now precedents that indicate that modalities focusing on pathogen-mediated manipulation of IL-10 signaling may have clinical benefit.

AB - Interleukin-10 (IL-10) is a tightly regulated, pleiotropic cytokine that has profound effects on all facets of the immune system, eliciting cell-type-specific responses within cells expressing the IL-10 receptor (IL-10R). It is considered a master immune regulator, and imbalances in IL-10 expression, resulting from either inherent or infectious etiologies, have far reaching clinical ramifications. Regarding infectious diseases, there has been accumulating recognition that many pathogens, particularly those that establish lifelong persistence, share a commonality of their natural histories: manipulation of IL-10-mediated signaling pathways. Multiple viral, bacterial, protozoal, and fungal pathogens appear to have evolved mechanisms to co-opt normal immune functions, including those involving IL-10R-mediated signaling, and immune effector pathways away from immune-mediated protection toward environments of immune evasion, suppression, and tolerance. As a result, pathogens can persist for the life of the infected host, many of whom possess otherwise competent immune systems. Because of pathogenic avoidance of immune clearance, persistent infections can exact incalculable physical and financial costs, and represent some of the most vexing challenges for improvements in human health. Enormous benefits could be gained by the development of efficient prevention and/or therapeutic strategies that block primary infection, or clear the infection. There are now precedents that indicate that modalities focusing on pathogen-mediated manipulation of IL-10 signaling may have clinical benefit.

UR - http://www.scopus.com/inward/record.url?scp=84906877078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906877078&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-43492-5-5

DO - 10.1007/978-3-662-43492-5-5

M3 - Chapter

SN - 9783662434918

VL - 380

T3 - Current Topics in Microbiology and Immunology

SP - 93

EP - 128

BT - Current Topics in Microbiology and Immunology

PB - Springer Verlag

ER -